Radiation Therapy

1. Treatment results of stage I oral tongue cancer with definitive radiotherapy.

Author
Ichimiya Y; Fuwa N; Kamata M; Kodaira T; Furutani K; Tachibana H; Tomita N; Hidano S; Ichimiya Y; Fuwa N; Kamata M; Kodaira T; Furutani K; Tachibana H; Tomita N; Hidano S;
Institution
Department of Radiation Oncology, Aichi Cancer Center, Aichi 464-8681, Japan. yichimiya@aichi-cc.jp
Journal
Oral Oncol. 2005 May;41(5):520-5. Epub 2005 Apr 9.
Abstract URL
Click here to view abstract

2. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.

Author
Karakoyun-Celik O; Norris CM Jr; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM; Karakoyun-Celik O; Norris CM Jr; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM;
Institution
Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Cox 3, Boston, MA 02114, USA.
Journal
Head Neck. 2005 May;27(5):353-61.
Abstract URL
Click here to view abstract

3. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.

Author
Kutter J; Ozsahin M; Monnier P; Stupp R;
Institution
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital (CHUV), Lausanne, Switzerland.
Journal
Eur Arch Otorhinolaryngol. 2005 Jan;262(1):1-7. Epub 2004 Mar 5.
Abstract URL
Click here to view abstract

4. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.

Author
Lazarus C; Logemann JA; Pauloski BR; Rademaker AW; Helenowski IB; Vonesh EF; Maccracken E; Mittal BB; Vokes EE; Haraf DJ;
Institution
Voice, Speech and Language Service and Swallowing Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Journal
Head Neck. 2007 Jul;29(7):632-7.
Abstract URL
Click here to view abstract

5. Definitive radiotherapy for squamous cell carcinoma of the base of tongue.

Author
Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Werning JW; Villaret DB; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Werning JW; Villaret DB; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Werning JW; Villaret DB;
Institution
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL 32610-0385, USA. mendewil@shands.ufl.edu
Journal
Am J Clin Oncol. 2006 Feb;29(1):32-9.
Abstract URL
Click here to view abstract

6. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.

Author
Bourgier C; Coche-Dequeant B; Fournier C; Castelain B; Prevost B; Lefebvre JL; Lartigau E;
Institution
Department of Radiotherapy, Centre Oscar Lambret, 3 rue Frederic Combemale, 59000 Lille, France.
Journal
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):434-40.
Abstract URL
Click here to view abstract

7. Curative Brachytherapy for Recurrent/Residual Tongue Cancer.

Author
Ayukawa F; Shibuya H; Yoshimura RI; Watanabe H; Miura M;
Institution
Department of Radiology, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo, 113-8519, Japan, ayukawa@yahoo.co.jp.
Journal
Strahlenther Onkol. 2007 Mar;183(3):133-137.
Abstract URL
Click here to view abstract

8. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.

Author
Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K;
Institution
Department of Radiology, National Hospital Organization Osaka National Hospital, Hoenzaka 2-1-14 Chuo-ku, Osaka city, Osaka 540-0006 Japan. hideya10@hotmail.com
Journal
Anticancer Res. 2007 Jan-Feb;27(1B):491-7.
Abstract URL
Click here to view abstract

9. Treatment of early tongue carcinoma with brachytherapy: results over a 25-year period.

Author
Urashima Y; Nakamura K; Shioyama Y; Nomoto S; Ohga S; Toba T; Yoshitake T; Chikui T; Kawazu T; Jingu K; Terashima H; Honda H;
Institution
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Journal
Anticancer Res. 2007 Sep-Oct;27(5B):3519-23.
Abstract URL
Click here to view abstract

10. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.

Author
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K; Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K; Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K;
Institution
Department of Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Osaka 565-0871, Japan. kakimoto@dent.osaka-u.ac.jp
Journal
Anticancer Res. 2006 Sep-Oct;26(5B):3933-7.
Abstract URL
Click here to view abstract

11. Interstitial brachytherapy as the sole treatment for tongue metastasis from breast carcinoma.

Author
Hannoun-Levi JM; Largillier R; Dassonville O;
Institution
Centre Antoine Lacassagne, Department of Radiotherapy, Nice, France. jean-michel-hannoun-levi@nice.fnclcc.fr
Journal
Rev Laryngol Otol Rhinol (Bord). 2006;127(3):191-2.
Abstract URL
Click here to view abstract

12. Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue.

Author
Urashima Y; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Toba T; Kunitake N; Chikui T; Kawazu T; Yamada T; Terashima H; Honda H;
Institution
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. urash@radiol.med.kyushu-u.ac.jp
Journal
Jpn J Clin Oncol. 2006 Nov;36(11):681-7. Epub 2006 Oct 4.
Abstract URL
Click here to view abstract